Lb Pharmaceuticals (LBRX) Other Working Capital Changes (2024 - 2026)
Lb Pharmaceuticals' (LBRX) quarterly Other Working Capital Changes came in at -$99000.0 in Q1 2026, down 5050.0% year-on-year from $2000.0 in Q1 2025, and down 1.02% quarter-over-quarter from -$98000.0 in Q4 2025.
Lb Pharmaceuticals (LBRX) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$99000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 5050.0% year-over-year to -$99000.0 in Q1 2026; TTM through Mar 2026 was -$194000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$134000.0, down 123.33% from the prior year.
- Other Working Capital Changes fell to -$99000.0 in Q1 2026 per LBRX's latest filing, from -$98000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $11.3 million in Q4 2025 and bottomed at -$83000.0 in Q1 2025.
- The 3-year median for Other Working Capital Changes is $5.1 million (2024), against an average of $5.4 million.
- Across the five-year window, Other Working Capital Changes sank 9900.0% in 2025 and tumbled 5050.0% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $1000.0 in 2024, then sank by 9900.0% to -$98000.0 in 2025, then declined by 1.02% to -$99000.0 in 2026.
- Per Business Quant, the three latest LBRX Other Working Capital Changes figures stand at -$99000.0 (Q1 2026), -$98000.0 (Q4 2025), and $2000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lb Pharmaceuticals | 977.73 Mn | 977.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99,000.00 |
| Mar 31, 2026 | -99,000.00 |
| Mar 31, 2026 | -99,000.00 |
| Dec 31, 2025 | -98,000.00 |
| Dec 31, 2025 | -98,000.00 |
| Dec 31, 2025 | -98,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |